技术突破+临床验证双轮驱动，这家公司脑机技术聚焦教育、医疗、养老三大核心应用场景！

Group 1 - The core viewpoint of the article emphasizes the rapid development and commercialization of brain-computer interface (BCI) technology in China, supported by government policies and a growing market potential [2][3]. - The National Healthcare Security Administration has introduced new pricing mechanisms for innovative drugs and medical technologies, including specific pricing for BCI-related services, which is expected to accelerate clinical application and commercialization [1][2]. - The comprehensive scale of China's BCI industry is projected to exceed 100 billion yuan, driven by supportive policies and increasing market demand [2]. Group 2 - The BCI technology is approaching a critical turning point in its industrialization process, with ongoing clinical trials validating its feasibility and optimizing performance metrics, thereby reducing technical risks [3]. - The investment cycle for BCI technology is suggested to be divided into three stages: medical application, consumer application, and downstream application expansion [3][4]. - Companies focusing on BCI-related business through technology collaboration, investment, or independent research and development are expected to benefit significantly in the initial application phase [4].